Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2026 10:00 ET | Source: BioBridge Global

BBG Advanced Therapies Launches Mobile Leukapheresis Center, in Collaboration with Kite to Bring CAR T-cell Therapies Closer to Patients

San Antonio, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- BBG Advanced Therapies, a subsidiary of nonprofit BioBridge Global (BBG), today announced a collaboration with Kite, a Gilead Company and global...
July 06, 2026 07:07 ET | Source: Pluristyx, Inc.

Pluristyx Inc. Secures Initial Close of Series A Priced Round with Multinational Fortune 500 Company; Round to Remain Open for Syndicate Partners Until September 2nd

Pluristyx secures a Series A priced round initial close led by a multinational Fortune 500 company to accelerate growth and expand its stem cell platform.
June 16, 2026 07:07 ET | Source: Pluristyx, Inc.

Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming Leadership

Pluristyx issued Japan patent allowance for next-gen synthetic mRNA, accelerating non-viral, footprint-free iPSC generation for regenerative medicine
June 09, 2026 05:00 ET | Source: AscellaHealth, LLC

AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity

AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity
June 03, 2026 07:00 ET | Source: Dark Horse Consulting Group

Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China

DHCG and Altruist Biologics sign MOU to give sponsors a streamlined path to world-class biologics manufacturing in China.
May 11, 2026 07:00 ET | Source: Dark Horse Consulting Group

Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China

DHCG and KunTuo sign MOU to give cell and gene therapy developers an integrated path to clinical trials in China via combined regulatory and CRO expertise.
April 26, 2026 23:30 ET | Source: Dark Horse Consulting Group

Dark Horse Consulting Group and Porton Advanced Announce Memorandum of Understanding Providing a Streamlined Path to Conducting IITs in China

DHCG and Porton Advanced sign MOU to streamline IITs in China, combining DHCG's consulting expertise with Porton's ATMP manufacturing capabilities
April 21, 2026 06:00 ET | Source: Dark Horse Consulting Group

Dark Horse Consulting Group’s Acquisition of CJ PARTNERS Provides Regional Expansion

DHCG acquires CJP, a consulting firm specializing in connecting Western and Eastern therapeutic developers, expanding DHCG's Asia Pacific presence.
April 07, 2026 07:09 ET | Source: Pluristyx, Inc.

Pluristyx Extends Patent Portfolio in Universal Cell Therapy with New U.S. Patent for iACT Stealth™ Technology

Pluristyx announces a new U.S. patent for iACT Stealth™ technology, enabling "cloaking" of cells to treat autoimmune diseases without immune suppression.
March 17, 2026 07:37 ET | Source: Pluristyx, Inc.

Organoid COMMONS Announces Formation of Governing Board, Appointment of Alliance Director, and Announces Open Call for New COMMONS Members

Organoid COMMONS appoints its Governing Board and Alliance Director. Member applications are open through April 30, 2026.